Bristol-Myers to buy Celgene in US$74 bil cancer-drug bet

BOSTON/NEW YORK (Jan 3): Bristol-Myers Squibb agreed to acquire Celgene Corp in a US$74 billion deal that will unite two drugmakers battling for advantage in…